| Greenwood DavidPresident, Interim CEO, CFO, Director · 38 transactions | — | 782.6K†as of Feb 2012 | 897.6K | — | 117.4K |
| Grethlein Andrew JEVP, Chief Operating Officer · 7 transactions | — | 674.3Kas of Jul 2024 | 1.06M | — | 1.06M |
| Lebkowski JaneSVP, Chief Scientific Officer · 31 transactions | — | 606.9K†as of Feb 2012 | 656.6K | — | 86.0K |
| Okarma ThomasPresident and CEO · 20 transactions | — | 572.1Kas of Jul 2010 | 915.7K | — | 114.0K |
| Earp DavidSVP, Corp Transactions · 32 transactions | — | 498.0K†as of May 2012 | 584.7K | — | 115.2K |
| Barkas Alexander EDirector · 23 transactions | — | 348.1Kas of May 2011 | 318.8K | — | — |
| Spink Katharine E.SVP Alliance Mgmt & Operations · 17 transactions | — | 344.4K†as of Feb 2012 | 350.0K | — | 34.8K |
| Molineaux SusanDirector · 27 transactions | — | 289.8K†as of Dec 2023 | 165.5K | — | 35.0K |
| Spiegel Robert J.Director · 70 transactions | — | 199.7K | 424.7K | — | 175.0K |
| Harley CalvinVP, CSO Telomerase Tech · 25 transactions | — | 198.7K†as of May 2009 | 243.6K | — | 99.7K |
| Fritzky Edward VDirector · 28 transactions | — | 186.5Kas of May 2013 | 229.4K | — | — |
| Kiley ThomasDirector · 25 transactions | — | 171.9Kas of May 2013 | 164.1K | 114.3K | — |
| Huh HoyoungDirector · 20 transactions | — | 154.3Kas of Dec 2017 | 219.3K | — | — |
| Scarlett John AChairman, President and CEO, Director · 11 transactions | — | 137.5K†as of Mar 2025 | 1.94M | 137.5K | 1.94M |
| Kelsey Stephen MichaelEVP, R&D, Chief Med Officer · 17 transactions | — | 125.9K†as of May 2013 | 462.8K | — | 32.0K |
| Rosenfield StephenEVP, Genl Counsel & Secretary · 14 transactions | — | 112.5Kas of Aug 2018 | 1.36M | — | 1.36M |
| Eastham KarinDirector · 17 transactions | — | 109.0Kas of Jan 2023 | 159.0K | — | — |
| Ziegler JamesEVP, Chief Commercial Officer · 1 transaction | — | 100.0Kas of Feb 2025 | — | 100.0K | — |
| Colowick AlanPresident, Oncology · 4 transactions | — | 92.8K†as of Jan 2008 | 12.7K | — | — |
| Walker John PeterDirector · 11 transactions | — | 87.7Kas of Jan 2009 | 106.2K | — | 48.6K |
| Bloom Olivia KyusukEVP, Chief Financial Officer · 19 transactions | — | 74.6Kas of Feb 2023 | 501.0K | — | 432.4K |
| Zenner Patrick JDirector · 9 transactions | — | 73.7Kas of May 2010 | 82.1K | — | — |
| Homcy Charles JDirector · 15 transactions | — | 62.8Kas of May 2011 | 120.3K | — | — |
| Bradbury DanielDirector · 8 transactions | — | 51.3Kas of Mar 2019 | 51.3K | 142.8K | — |
| Benedetti Fabio MSVP, Chief Med Off, Oncology · 7 transactions | — | 41.0K†as of May 2009 | 67.5K | — | 7.5K |
| O'Farrell Elizabeth G.Director · 5 transactions | — | 33.6K†as of Aug 2023 | — | 33.6K | — |
| Robertson MichelleEVP, CHIEF FINANCIAL OFFICER · 2 transactions | — | 27.5K | 27.5K | — | 9.9K |
| Samuels Scott AlanEVP, Chief Legal Officer · 1 transaction | — | 26.7Kas of Feb 2025 | — | 15.0K | — |
| Hofstaetter ThomasDirector · 17 transactions | — | 26.6Kas of Mar 2015 | 146.6K | — | 70.0K |
| Nallicheri Melanie ISVP Corp Dev · 6 transactions | — | 25.0K†as of Feb 2012 | 180.0K | — | — |
| Feller FayeEVP, Chief Medical Officer · 4 transactions | — | 20.0Kas of Jun 2024 | 287.9K | — | 287.9K |
| Lawlis V BryanDirector · 5 transactions | — | 13.3Kas of May 2025 | 70.0K | 13.3K | 70.0K |
| Aggarwal GauravDirector · 1 transaction | — | 2.0Kas of Dec 2023 | 2.0K | — | — |
| Kapur AnilEVP, Corp Strategy & CCO · 5 transactions | — | 0as of Jun 2024 | 448.5K | — | 421.9K |
| Behrs Melissa KellyEVP, Chief Business Officer · 42 transactions | — | 0as of Apr 2019 | 531.1K | — | 302.5K |